RACHEL BURT: Open Payments
NPI 1417685389 · N CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,418 in 130 payments from 45 companies in 2025. Trend: 2023 $550 · 2024 $2,479 · 2025 $3,418
Food & beverage: $3,218Education: $200
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 4 | $280 |
| Celgene Corporation | 12 | $250 |
| AstraZeneca Pharmaceuticals LP | 11 | $219 |
| Merck Sharp & Dohme LLC | 8 | $180 |
| ABBVIE INC. | 4 | $179 |
| Janssen Biotech, Inc. | 4 | $168 |
| Novartis Pharmaceuticals Corporation | 7 | $163 |
| Daiichi Sankyo Inc. | 5 | $130 |
| PFIZER INC. | 6 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
Products named: Vonjo, REBLOZYL, KEYTRUDA, DARZALEX, BRUKINSA, Trodelvy, VERZENIO, BESREMI.
Industry payments across SC — which companies pay providers there.
